The Valley Desk

Clinical trial reportClinical lymphoma, myeloma & leukemiaPublished

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical lymphoma, myeloma & leukemia
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Pain; Antineoplastic Agents; Quality of Life; Patient Reported Outcome Measures; Bispecific antibody; Patient-reported Outcomes; Eortc Qlq-c30; Eq-5d-5l; B-cell Maturation Antigen
PubMed ID
38052709
Added to directory
Source checked

Report a correction or request removal